Search research articles
Contact Us
Filters
Showing results (81-90 of 91) with videos related to
Page
of 10
Sort By:
American Heart Journal
|
June 20, 2006
Impact of infarct location on left ventricular ejection fraction after correction for enzymatic infarct size in acute myocardial infarction treated with primary coronary intervention
Peter Elsman, Arnoud W J van 't Hof, Menko-Jan de Boer, et al.
The American Journal of Cardiology
|
April 18, 2006
Effect of coronary occlusion site on angiographic and clinical outcome in acute myocardial infarction patients treated with early coronary intervention
Peter Elsman, Arnoud W J van 't Hof, Jan C A Hoorntje, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 3, 2012
Cerebrospinal fluid amyloid-β and phenotypic heterogeneity in de novo Parkinson's disease
Guido Alves, Kenn Freddy Pedersen, Bastiaan R Bloem, et al.
Neurocritical Care
|
November 10, 2012
Outcome prediction in moderate and severe traumatic brain injury: a focus on computed tomography variables
Bram Jacobs, Tjemme Beems, Ton M van der Vliet, et al.
International Journal of Nursing Studies
|
March 23, 2011
Fewer adverse events as a result of the SAFE or SORRY? programme in hospitals and nursing homes. part i: primary outcome of a cluster randomised trial
Betsie G I van Gaal, Lisette Schoonhoven, Joke A J Mintjes, et al.
The New England Journal of Medicine
|
August 14, 2009
Micrometastases or isolated tumor cells and the outcome of breast cancer
Maaike de Boer, Carolien H M van Deurzen, Jos A A M van Dijck, et al.
Breast Cancer Research and Treatment
|
October 10, 2013
Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome
Dorien J A Lobbezoo, Roel J W van Kampen, Adri C Voogd, et al.
European Journal of Human Genetics : EJHG
|
June 2, 2005
Genotype-phenotype studies in nail-patella syndrome show that LMX1B mutation location is involved in the risk of developing nephropathy
Ernie M H F Bongers, Frans T Huysmans, Elena Levtchenko, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2013
Primary granulocyte colony-stimulating factor prophylaxis during the first two cycles only or throughout all chemotherapy cycles in patients with breast cancer at risk for febrile neutropenia
Maureen J Aarts, Frank P Peters, Caroline M Mandigers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 30, 2013
Cost effectiveness of primary pegfilgrastim prophylaxis in patients with breast cancer at risk of febrile neutropenia
Maureen J Aarts, Janneke P Grutters, Frank P Peters, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 91) with videos related to
Sort By:
Page
of 10
American Heart Journal
|
June 20, 2006
Impact of infarct location on left ventricular ejection fraction after correction for enzymatic infarct size in acute myocardial infarction treated with primary coronary intervention
Peter Elsman, Arnoud W J van 't Hof, Menko-Jan de Boer, et al.
The American Journal of Cardiology
|
April 18, 2006
Effect of coronary occlusion site on angiographic and clinical outcome in acute myocardial infarction patients treated with early coronary intervention
Peter Elsman, Arnoud W J van 't Hof, Jan C A Hoorntje, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 3, 2012
Cerebrospinal fluid amyloid-β and phenotypic heterogeneity in de novo Parkinson's disease
Guido Alves, Kenn Freddy Pedersen, Bastiaan R Bloem, et al.
Neurocritical Care
|
November 10, 2012
Outcome prediction in moderate and severe traumatic brain injury: a focus on computed tomography variables
Bram Jacobs, Tjemme Beems, Ton M van der Vliet, et al.
International Journal of Nursing Studies
|
March 23, 2011
Fewer adverse events as a result of the SAFE or SORRY? programme in hospitals and nursing homes. part i: primary outcome of a cluster randomised trial
Betsie G I van Gaal, Lisette Schoonhoven, Joke A J Mintjes, et al.
The New England Journal of Medicine
|
August 14, 2009
Micrometastases or isolated tumor cells and the outcome of breast cancer
Maaike de Boer, Carolien H M van Deurzen, Jos A A M van Dijck, et al.
Breast Cancer Research and Treatment
|
October 10, 2013
Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome
Dorien J A Lobbezoo, Roel J W van Kampen, Adri C Voogd, et al.
European Journal of Human Genetics : EJHG
|
June 2, 2005
Genotype-phenotype studies in nail-patella syndrome show that LMX1B mutation location is involved in the risk of developing nephropathy
Ernie M H F Bongers, Frans T Huysmans, Elena Levtchenko, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2013
Primary granulocyte colony-stimulating factor prophylaxis during the first two cycles only or throughout all chemotherapy cycles in patients with breast cancer at risk for febrile neutropenia
Maureen J Aarts, Frank P Peters, Caroline M Mandigers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 30, 2013
Cost effectiveness of primary pegfilgrastim prophylaxis in patients with breast cancer at risk of febrile neutropenia
Maureen J Aarts, Janneke P Grutters, Frank P Peters, et al.
Page
of 10